XML 52 R36.htm IDEA: XBRL DOCUMENT v3.23.4
Share-Based Compensation (Tables)
12 Months Ended
Nov. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Compensation Expense
A summary of share-based compensation expense in the Consolidated Statements of Operations for TD SYNNEX stock incentive plans is presented below:
Fiscal Years Ended November 30,
202320222021
(currency in thousands)
Selling, general and administrative expenses$49,273 $38,994 $33,078 
Acquisition, integration and restructuring costs
6,526 6,514 8,289 
Total share-based compensation expense$55,799 $45,508 $41,367 
Summary of Changes in Company Stock Option Activity
A summary of the changes in the Company’s stock options is set forth below:
Options Outstanding
(shares in thousands, except per share amounts)
Number of
shares
Weighted-
average exercise
price per share
Balances, November 30, 2022677$72.29 
Options exercised(83)53.46 
Balances, November 30, 2023594$74.93 
Schedule of Assumptions Used in Black-Scholes Valuation Model
The following assumptions were used in the Black-Scholes valuation model in fiscal years 2022 and 2021:
Fiscal Years Ended November 30,
20222021
Expected life (years)
5.5
5.5 - 6.1
Risk free interest rate
1.73% - 3.92%
0.72% - 1.16%
Expected volatility
39.10% - 40.18%
38.01% - 38.85%
Dividend yield
1.13% - 1.37%
0.75% - 0.88%
Schedule of Cash Received from Exercise of Options and intrinsic Values of Options Exercised
The cash received from the exercise of stock options and the intrinsic values of stock options exercised during fiscal years 2023, 2022 and 2021 were as follows:
Fiscal Years Ended November 30,
202320222021
(currency in thousands)
Intrinsic value of options exercised$3,570 $4,682 $16,163 
Cash received from exercise of options$4,448 $3,216 $10,541 
Summary Changes in Non-vested Restricted Stock Awards and Stock Units
A summary of the changes in the Company’s non-vested RSAs and RSUs during fiscal year 2023 is presented below:
(shares in thousands, except per share amounts)
Number of
shares
Weighted-average,
grant-date
fair value per share
Non-vested as of November 30, 20221,307$95.69 
Granted
63596.75 
Vested
(544)100.07 
Attainment adjustments(1)
(12)91.34 
Cancelled
(79)92.73 
Non-vested as of November 30, 20231,307$94.92 
__________________
(1) During the year ended November 30, 2023, the attainment on PRSUs vested was adjusted to reflect actual performance.
The following table summarizes the activity related to these restricted shares during the year ended November 30, 2023:
(share amounts in thousands)
Restricted shares
Nonvested as of November 30, 2022
350
Vested(316)
Canceled(34)
Nonvested as of November 30, 2023
0